3 ms·
That's vaccines and there are regulatory issues in the US with them, antibiotics are perfectly profitable. Also, only in the US does profitability seem to affe
by fleitz 10y ago
That's vaccines and there are regulatory issues in the US with them, antibiotics are perfectly profitable.
Also, only in the US does profitability seem to affect making basic medicines. Bacterial resistance is a global issue, not just one like vaccines that is largely a US issue.
- refurb 10y agoAntibiotics aren't generally that profitable in the US. The first reason is antibiotic stewardship: make a really great antibiotic and nobody wants to use it unless they have to. The other reason is that the way antibiotics are reimbursed in the hospital setting prevents charging a price that makes it all that profitable.